Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$247M |
| 2 |
Johnson & Johnson
JNJ
|
+$225M |
| 3 |
MON
Monsanto Co
MON
|
+$213M |
| 4 |
AET
Aetna Inc
AET
|
+$208M |
| 5 |
Broadcom
AVGO
|
+$176M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$227M |
| 2 |
Microsoft
MSFT
|
+$224M |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$205M |
| 4 |
Nike
NKE
|
+$187M |
| 5 |
Pfizer
PFE
|
+$184M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 14.12% |
| 2 | Technology | 12.96% |
| 3 | Healthcare | 12.08% |
| 4 | Industrials | 11.23% |
| 5 | Consumer Staples | 8.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
101
Simon Property Group
SPG
$74.5B
| $110M | 0.17% |
+620,505
| New | +$115M |
|
102
Adeia
ADEA
$2.86B
| $110M | 0.17% |
9,411,822
+679,213
| +8% | +$7.2M |
|
|
RTN
103
DELISTED
Raytheon Company
RTN
| $110M | 0.17% |
774,400
+708,500
| +1,075% | +$101M |
|
|
BRFS
104
DELISTED
BRF SA
BRFS
| $110M | 0.17% |
7,421,400
-1,433,100
| -16% | -$22.6M |
|
105
Telus
TU
$16B
| $109M | 0.17% |
6,861,200
+59,800
| +0.9% | +$953K |
|
106
ICU Medical
ICUI
$3.93B
| $109M | 0.17% |
739,700
+700
| +0.1% | +$101K |
|
107
Capitol Federal Financial
CFFN
$1.08B
| $106M | 0.17% |
6,456,858
+303,900
| +5% | +$4.67M |
|
|
STJ
108
DELISTED
St Jude Medical
STJ
| $105M | 0.17% |
+1,310,913
| New | +$104M |
|
109
Berkshire Hathaway Class A
BRK.A
$1.07T
| $104M | 0.16% |
425
+64
| +18% | +$14.8M |
|
|
CSGS
110
DELISTED
CSG Systems International
CSGS
| $104M | 0.16% |
2,141,352
-124,047
| -5% | -$5.34M |
|
111
Healthpeak Properties
DOC
$15.4B
| $104M | 0.16% |
3,485,200
+1,973,034
| +130% | +$60.1M |
|
|
ESV
112
DELISTED
Ensco Rowan plc
ESV
| $103M | 0.16% |
2,639,790
+305,409
| +13% | +$10.9M |
|
113
NXP Semiconductors
NXPI
$68B
| $102M | 0.16% |
1,041,088
+933,100
| +864% | +$92.7M |
|
114
BlackBerry
BB
$5.01B
| $101M | 0.16% |
14,669,200
-4,109,343
| -22% | -$30.5M |
|
115
Usana Health Sciences
USNA
$394M
| $99.9M | 0.16% |
1,632,900
+33,734
| +2% | +$2.2M |
|
116
Xerox
XRX
$337M
| $99.6M | 0.16% |
4,331,040
+2,613,124
| +152% | +$65.1M |
|
117
Ciena
CIEN
$55.3B
| $98.4M | 0.16% |
4,032,274
+2,167,574
| +116% | +$47.4M |
|
118
Motorola Solutions
MSI
$69.4B
| $98.4M | 0.16% |
1,186,765
-146,450
| -11% | -$11.5M |
|
119
Comcast
CMCSA
$79.1B
| $98.2M | 0.16% |
2,844,726
+2,486,050
| +693% | +$83M |
|
120
D.R. Horton
DHI
$41B
| $97.6M | 0.15% |
3,570,838
+2,196,400
| +160% | +$62.8M |
|
121
Progressive
PGR
$124B
| $97.4M | 0.15% |
2,742,869
+228,869
| +9% | +$7.57M |
|
|
TSE
122
DELISTED
Trinseo
TSE
| $97.3M | 0.15% |
1,641,400
+217,600
| +15% | +$12.2M |
|
|
MBT
123
DELISTED
Mobile TeleSystems Public Joint Stock Company American Depositary Shares (Each representing 2 Shares
MBT
| $97M | 0.15% |
10,650,750
+1,529,450
| +17% | +$12.3M |
|
124
Honda
HMC
$36.5B
| $96.6M | 0.15% |
3,310,400
-273,800
| -8% | -$8.04M |
|
|
SRCL
125
DELISTED
Stericycle Inc
SRCL
| $96.2M | 0.15% |
1,249,020
+1,096,400
| +718% | +$82.8M |
|
Similar funds
Renaissance Technologies's Q4 2016 Portfolio in Review
As of Q4 2016, Renaissance Technologies held 3,715 positions worth $63.2B, up 12% from $56.6B the previous quarter. Its ten largest holdings account for 7.2% of the portfolio.
Renaissance Technologies deployed $5.07B of net new capital in Q4 2016, opening 418 new positions and adding to 1,792 existing holdings. Its largest new stake was Broadcom: 10,144,960 shares worth $179M.
By sector, the portfolio is most concentrated in Financials at 14% of assets, up from 12% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was Bristol-Myers Squibb, an estimated $227M trimmed.
- Renaissance Technologies's largest Q4 2016 buy was Broadcom: 10,144,960 shares worth $179M.
- Renaissance Technologies added most to Gilead Sciences in Q4 2016, an estimated $247M increase.
- Renaissance Technologies's biggest Q4 2016 reduction was Bristol-Myers Squibb, cutting an estimated $227M.
- Renaissance Technologies fully exited Alphabet (Google) Class C in Q4 2016, selling an estimated $205M.
- Renaissance Technologies's ten largest holdings make up 7.2% of its $63.2B portfolio in Q4 2016.
- Renaissance Technologies opened 418 new positions and closed 494 in Q4 2016.
- Renaissance Technologies's portfolio value rose 12% quarter-over-quarter to $63.2B.
Based on Renaissance Technologies's 13F filing for Q4 2016, filed 13 Feb 2017.